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1078–5884/00Risk Factors for Delayed Healing and Recurrence of Chronic
Venous Leg Ulcers—An Analysis of 1324 Legs
M.S. Gohel, M. Taylor, J.J. Earnshaw, B.P. Heather, K.R. Poskitt and M.R. Whyman*Cheltenham General Hospital, Sandford Road, Cheltenham, Gloucestershire GL53 7AN, UKObjective. Despite similar disease patterns and treatment, there is great variation in clinical outcome between venous ulcer
patients. The aim of this study was to identify independent risk factors for venous ulcer healing and recurrence.
Methods. Consecutive patients assessed by a specialist nurse-led leg ulcer service between January 1998 and July 2003 with
an ABPIO0.85 were included in this study. Independent risk factors for healing and recurrence were identified from
routinely assessed variables using a Cox regression proportional hazards model.
Results. A total of 1324 legs in 1186 patients were studied. The 24-week healing rate was 76% and 1 year recurrence rate
was 17% (Kaplan–Meier life table analysis). Patient age (p!0.001, HR per year 0.989, 95% CI 0.984–0.995) and ulcer
chronicity (pZ0.019, HR per month 0.996, 95% CI 0.993–0.999) were independent risk factors for delayed ulcer healing.
Ulcer healing time (p!0.001, HR per week 1.016, 95% CI 1.007–1.026) and superficial venous reflux not treated with
surgery (pZ0.015, HR 2.218, 95% CI 1.166–4.218) were independent risk factors for ulcer recurrence.
Conclusions. Elderly patients with longstanding ulcers should be targeted for further research and may benefit from
adjunctive treatments to improve clinical outcomes. Patients not treated with superficial venous surgery were at increased
risk of leg ulcer recurrence.Keywords: Venous ulceration; Healing; Recurrence; Risk factor; Colour venous duplex.Introduction
Chronic leg ulcers affect more than 1% of the
population1,2 with an estimated health service cost of
£400–600 million per annum in the UK.3 The mainstay
of treatment for chronic venous ulceration is com-
pression bandaging,4,5 although other treatments such
as debridement,6 skin grafting7–9 or novel new treat-
ments such as vacuum therapy10,11 or biological
dressings12 may also be helpful particularly in those
patients not improving with standard treatment.
Despite similar disease patterns and treatment, there
is great variation in clinical outcome between individ-
ual patients. An effective method of predicting out-
come by identifying appropriate risk factors may
allow better provision of service and greater accuracy
in informing patients of their prognosis. The ability to
identify those patients with unfavourable clinical
outcomes may also encourage changes in treatment
at an early stage.ing author. M.R. Whyman, Department of Vascular
ltenham General Hospital, Sandford Road, Chelten-
tershire GL53 7AN, UK.
: mark.whyman@egnhst.org.uk
0074 + 04 $35.00/0 q 2004 Elsevier Ltd. All rights reserThe aim of this study was to assess whether a
number of routinely assessed variables could be used
to predict healing and recurrence in patients with
chronic venous leg ulceration.MethodsSetting and patients
All patients in this study were assessed in the
Gloucestershire leg ulcer service, an open access
nurse-led specialist resource.13 The service has been
operating since 1995 and runs central and peripheral
clinics throughout Gloucestershire in the UK. New
patients referred to the service were invited to attend a
one-stop leg ulcer assessment consisting of clinical
assessment by the leg ulcer nurse specialist, measure-
ment of ankle brachial pressure index (ABPI) using
handheld Doppler (Huntleigh, Cardiff, UK) and
colour duplex imaging (H.P. Sonos 2000, Hewlett
Packard, MA) (Fig. 1).
Duplex scans were performed by accredited vas-
cular technologists. As well as long saphenous, shortEur J Vasc Endovasc Surg 29, 74–77 (2005)
doi:10.1016/j.ejvs.2004.10.002, available online at http://www.sciencedirect.com onved.
Fig. 1. Treatment protocol of patients included in study.
Risk Factors for Venous Ulcer Outcome 75saphenous and calf perforating veins, the femoral,
above-knee and below-knee popliteal deep venous
segments were routinely insonated. Venous reflux of
O1 s was considered to be significant. Limbs with
reflux in all three deep venous segments were
described as having total deep reflux and limbs with
reflux in one or two of the deep segments had
segmental deep reflux. A variety of possible risk
factors for poor ulcer healing or recurrence were
routinely documented for each patient (Table 1).
Patients were asked about rheumatoid arthritis,
diabetes mellitus and previous deep venous thrombo-
sis, although these diagnoses were not objectively
verified.
Patients seen between January 1998 and July 2003
with open or recently healed leg ulceration of O4
weeks duration (CEAP grades C5 and C6) and ABPIO
0.85 were included in this study. Details of initial
assessments and healing and recurrence dates wereTable 1. Risk factors for healing and recurrence of chronic venous le
Risk factor Ulcer healing
Hazard ratio
Age (per year) 0.989 (0.984–
Male sex (nZ508) 1.02 (0.88–1.1
Right leg (nZ609) 1.04 (0.91–1.2
History of deep venous thrombosis (nZ138) 0.81 (0.64–1.0
Diabetes mellitus (nZ129) 1.03 (0.82–1.2
Rheumatoid arthritis (nZ85) 0.82 (0.62–1.0
Ulcer chronicity (per month) 0.996 (0.993–
Segmental deep reflux (versus no deep reflux)
(nZ261)
0.99 (0.82–1.2
Total deep reflux (versus no deep reflux) (nZ228) 0.88 (0.71–1.0
Presence of incompetent calf perforating veins
(nZ382)
1.00 (0.86–1.1
Superficial venous reflux—no surgery (nZ1168) 1.13 (0.95–1.3
Superficial venous reflux—treated with surgery
(nZ156)
1.07 (0.82–1.3
Ulcer healing time (per week)
Cox regression analysis, proportional hazards mode.recorded prospectively on a computerised
spreadsheet.Treatment
Patients with open ulcers were treated with weekly
multilayer compression bandaging (Profore, Smith
and Nephew, Hull, UK) until ulcer healing, defined
as complete re-epithelialisation of the wound. Some
patients included in this study underwent superficial
venous surgery to correct long or short saphenous vein
reflux as part of a clinical trial within the unit. In cases
of suspicious ulcer appearance or poor healing, ulcer
margin biopsies were taken to exclude malignancy.
Some large ulcers were treated with pinch skin grafts if
judged to be appropriate by the assessing nurse
specialist.
Once healed, patients were given class II elastic
compression stockings (Duomed, Medi UK) and
reviewed on a 3 monthly basis up to 1 year and
annually thereafter for a ‘well leg’ assessment. Patients
were advised to continue wearing stockings long-term
although compliance was not formally assessed.
Stockings were provided by the NHS and replace-
ments were available 3 monthly. All patients were
advised to return to the open access clinic if ulceration
recurred.Statistical analysis
Twenty-four week healing and 12 month recurrence
rates were calculated using Kaplan–Meier survival
analyses.14 Specific risk factors for ulcer healing and
recurrence were assessed using the Cox regression
proportional hazards model. Only healed legs wereg ulcers
Ulcer recurrence
(95% CI) P value Hazard ratio (95% CI) P value
0.995) !0.001 1.00 (0.98–1.02) 0.93
8) 0.80 0.79 (0.53–1.19) 0.26
0) 0.56 0.82 (0.55–1.20) 0.30
2) 0.08 0.77 (0.40–1.49) 0.44
9) 0.83 1.05 (0.54–2.03) 0.90
8) 0.16 1.09 (0.44–2.72) 0.86
0.999) 0.019 1.00 (1.00–1.01) 0.18
0) 0.92 1.02 (0.60–1.75) 0.93
9) 0.24 1.25 (0.71–2.19) 0.45
8) 0.98 0.69 (0.44–1.06) 0.09
5) 0.18 2.218 (1.166–4.218) 0.015
9) 0.62 0.83 (0.33–2.04) 0.68
1.016 (1.007–1.026) !0.001
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M. S. Gohel et al.76included in the analysis for ulcer recurrence. Hazard
ratios and 95% confidence intervals were calculated.
All analyses were performed using statistical package
for social sciences (SPSS) advanced statistical software
(version 11.5; SPSS, Chicago, USA).Results
A total of 2283 legs were assessed by the leg ulcer
service between January 1998 and July 2003. Of these,
959 legs were excluded from this study for reasons of
co-existent arterial disease (406), absence of follow-up
information (444) or lack of ABPI/duplex investi-
gations (109). The remaining 1324 legs in 1186
consecutive patients with an ABPIO0.85 were
included in this analysis. At presentation, 1004 legs
had open ulceration (CEAP C6) and 320 were healed
(CEAP C5). Of these, 1195 legs satisfied the inclusion
criteria for the ulcer recurrence analysis.Ulcer healing
Overall healing rate was 76% at 24 week (Kaplan–
Meier survival analysis). A total of 12 risk factors were
assessed using the Cox regression model (Table 1).
Greater patient age (P!0.001, hazard ratio per year
0.989, 95% CI 0.984–0.995) and ulcer chronicity (PZ
0.019, hazard ratio per month 0.996, 95% CI 0.993–
0.999) were identified as independent risk factors for
ulcer healing.Ulcer recurrence
The ulcer recurrence rate at 12 month was 17%
(Kaplan–Meier survival analysis). Of 13 risk factors
assessed, greater ulcer healing time (P!0.001, hazard
ratio per week 1.016, 95% CI 1.007–1.026) and the
presence of superficial venous reflux not treated with
surgery (PZ0.015, hazard ratio 2.218, 95% CI 1.166–
4.218) were identified as independent risk factors for
ulcer recurrence (Table 1).Discussion
A previous risk factor study from our unit assessed a
different cohort of patients and identified patient age
and ulcer chronicity as risk factors for poor ulcer
healing.15 These findings were confirmed by the
present study. Advanced patient age is associated
with delayed healing of many wounds other than
venous ulcers.16 Other factors affecting elderlyEur J Vasc Endovasc Surg Vol 29, January 2005patients such as poor mobility and reduced tolerance
for compression treatments may also have contributed
to slow ulcer healing. Poor healing in long standing
ulcers may simply represent a greater severity of
underlying venous disease, although this finding may
also be due to senescence of fibroblasts which have
been shown to have a reduced response to prolifera-
tive stimuli after prolonged exposure to the chronic
venous ulcer environment.17–19 In this study, co-
existing diabetes was not associated with delayed
healing. However, this may be explained by the fact
that many diabetic patients have underlying arterial
disease and all patients with ABPI!0.85 were
excluded from this analysis.
Slow ulcer healing time was a risk factor for
recurrence, possibly a reflection of more severe
underlying venous dysfunction. Interestingly, limbs
with superficial venous reflux not treated with
saphenous surgery were at increased risk of recur-
rence. This finding supports other evidence suggesting
that surgical correction of superficial reflux reduces
venous ulcer recurrence.20–22 The lack of improvement
in healing after saphenous surgery suggests that
multilayer bandaging can match superficial venous
surgery in terms of correction of venous dysfunction,
but class II elastic stockings used for healed legs are
less effective in preventing ulcer recurrence.
The previous risk factor analysis suggested that the
presence of rheumatoid arthritis or popliteal vein
incompetence is a risk factor for poor clinical out-
come.15 These findings were not substantiated by the
present, larger study. Indeed, many duplex findings
traditionally considered to represent more severe
venous disease, such as total deep reflux or the
presence of incompetent calf perforating veins were
not associated with delayed healing or increased
recurrence. This amplifies the current lack of under-
standing of venous ulcer pathology that exists.
The identification of independent risk factors
allows patients to be accurately informed about their
prognosis and may help guide health service pro-
vision. In addition, early identification of patients
likely to have a poor clinical outcome may allow
clinicians the opportunity to alter management strat-
egies at a stage where fibroblasts are more likely to
respond to mitogenic stimuli. Patients at increased risk
of slow healing or ulcer recurrence should also be
targeted for further research to increase current
understanding and improve clinical outcomes.
The risk factors included in this study were limited
to those routinely assessed by the Gloucestershire leg
ulcer service. Other factors such as nutritional status,23
smoking,24 psychological state,25 ankle mobility26 or
speculatively, venous refill time may also be
Fig. 2. The multi-factorial aetiology of delayed ulcer healing.
The importance of individual factors may vary greatly
between patients.
Risk Factors for Venous Ulcer Outcome 77independent predictors of clinical outcome. A possible
explanation for the relative lack of independent risk
factors in this study may be the multi-factorial nature
of chronic venous ulceration (Fig. 2). Many specific
attributes have been associated with delayed wound
healing. Legs with venous ulcers usually have venous
hypertension. However, many limbs with venous
disease do not progress to ulceration, suggesting that
other factors are necessary for this progression. It is
probable that factors such as poor nutrition, reduced
mobility and co-existing illness are of greater import-
ance than previously assumed. It is also likely that the
significance of specific risk factors will vary greatly
between patients, suggesting that a holistic and
individual approach is warranted in all leg ulcer
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